Back to ROYAL BANK OF CANADA ROYAL BANK OF CANADA

EPRXEPRX
7 quarters

Position history for ROYAL BANK OF CANADAROYAL BANK OF CANADA's holdings in EUPRAXIA PHARMACEUTICALS INC

ROYAL BANK OF CANADA holds 311,435 shares of EPRX (EUPRAXIA PHARMACEUTICALS INC), worth $2.1M as of 2026-Q2. The position was increased (+19.1% shares). EPRX represents 0.0% of ROYAL BANK OF CANADA's portfolio.

Current Value

$2.1M

Current Shares

311,435

Total Value Change

+$1.2M

Total Shares Change

+28,290

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
311,435
+19.1%
$2.1M0.0%$6.61
31
2026-Q1
Increased
261,376
+33.2%
$1.9M0.0%$8.02
33
2025-Q4
Decreased
196,277
-54.2%
$1.5M0.0%$7.59
0
2025-Q3
Decreased
428,804
-50.0%
$2.5M0.0%$5.75
0
2025-Q2
Increased
857,168
+150.0%
$4.9M0.0%$5.30
43
2025-Q1
Increased
342,828
+21.1%
$1.1M0.0%$3.38
30
2024-Q4
New
283,145
-
$898,0000.0%$3.09
34

Other major holders of EPRX: BALYASNY ASSET MANAGEMENT L.P., SCOTIA CAPITAL INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used